Clinical Edge Journal Scan

Gastric cancer: Preoperative body composition predicts complication risk


 

Key clinical point: The body composition variables were associated with major postoperative complications in patients with gastric cancer who received preoperative chemotherapy followed by gastrectomy.

Major finding: A high skeletal muscle (SM)-mass Z-score (difference in each patient’s standard deviation from the mean value) was associated with a lower risk for major postoperative complications (relative risk [RR] 0.47, P = .004). High visceral adipose tissue-radiation attenuation (VAT-RA; RR 2.82; P = .001) and subcutaneous adipose tissue-RA (SAT-RA; RR 1.95; P = .015) Z-scores were associated with an increased risk for major postoperative complications.

Study details: This was a side study of 112 patients with gastric cancer who received preoperative chemotherapy followed by gastrectomy in the LOGICA trial. The preoperative computed tomography scan was used to calculate the mass and RA for SM, VAT, and SAT.

Disclosures: This study was sponsored by the Netherlands Organization for Health Research and Development. The authors received consulting or advisory fees, travel or accommodations expenses, or grants outside this work.

Source: Tweed TTT et al. Body composition is a predictor for postoperative complications after gastrectomy for gastric cancer: A prospective side study of the LOGICA trial. J Gastrointest Surg. 2022 (Apr 29). Doi: 10.1007/s11605-022-05321-0

Recommended Reading

NeoChemo preserves rectum in half of patients with rectal cancer
MDedge Hematology and Oncology
Gallstone disease may be a harbinger of pancreatic cancer
MDedge Hematology and Oncology
Stroke in the young: Cancer in disguise?
MDedge Hematology and Oncology
Jury is in? Survival benefit with lap surgery for rectal cancer
MDedge Hematology and Oncology
Improved cancer survival in states with ACA Medicaid expansion
MDedge Hematology and Oncology
AUA 2022: A report from the trenches
MDedge Hematology and Oncology
Advanced gastric cancer: Taxane-based chemotherapy regimen improves outcomes
MDedge Hematology and Oncology
Serum pepsinogen is associated with gastric cancer risk
MDedge Hematology and Oncology
Gastric cancer: Oxaliplatin and cisplatin confer similar survival in elderly patients
MDedge Hematology and Oncology
Gastric cancer: First-degree relatives show high prevalence of precancer lesions
MDedge Hematology and Oncology